NPPA notified regarding the computation of the retail price of Telmisartan IP 40 mg + Cilnidipine IP 10 mg + Metoprolol Succinate IP 47.5 mg Eq. to Metoprolol Tartrate 50 mg (As extended-release form) for M/s Mascot Health Series Pvt. Ltd. (Manufacturer) & M/s Intas Pharmaceuticals Ltd. (Marketer)

Feb 27, 2026 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific Complianceclass="MsoNormal" style="text-align: justify;">The National Pharmaceutical Pricing Authority (NPPA), on February 26, 2026, notified regarding the computation of the retail price of Telmisartan IP 40 mg + Cilnidipine IP 10 mg + Metoprolol Succinate IP 47.5 mg Eq. to Metoprolol Tartrate 50 mg (As extended-release form) for M/s Mascot Health Series Pvt. Ltd. (Manufacturer) & M/s Intas Pharmaceuticals Ltd. (Marketer).

It states that the price of each film-coated bilayer tablet containing:- Telmisartan IP 40 mg + Cilnidipine IP 10 mg + Metoprolol Succinate IP 47.5 mg Eq. to Metoprolol Tartrate 50 mg (As extended-release form) for M/s Mascot Health Series Pvt. Ltd. (Manufacturer) & M/s Intas Pharmaceuticals Ltd. (Marketer) has been revised to Rs. 14.49/-.

 

[Notification no: 19(5053)/2026/DP/NPPA/Div.II]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT